Mesangial expression of perlecan and agrin was reported in human diffuse mesangial sclerosis [34], in diabetic nephropathy [35], [36], and some other human glomerulopathies with mesangial expansion [37]. This evidence concerns the gene HSPG2 and lipoprotein glomerulopathy.